
- File Size 1.80 MB
- File Count 1
- Create Date January 28, 2025
- Last Updated January 28, 2025
Roche Holding: Q4 2024 Comprehensive Evaluation
Roche Holding AG is a global leader in pharmaceuticals and diagnostics, with a primary focus on developing innovative solutions for cancer, immune diseases, and infectious diseases. Headquartered in Basel, Switzerland, Roche operates in more than 100 countries worldwide, providing a broad portfolio of medicines and diagnostic tools that help improve patient outcomes and healthcare efficiencies.